Coronary Artery Disease remains the leading cause of morbidity and mortality worldwide, driven by plaque buildup, inflammation, endothelial dysfunction, and modifiable lifestyle factors. This session explores epidemiology, pathophysiology, diagnostic evaluation, and comprehensive management strategies for both obstructive and non-obstructive disease. As clinicians seek a dedicated cardiology conference, this session bridges foundational understanding with cutting-edge research and clinical application.

Participants will review plaque biology, lipid metabolism, thrombosis, microvascular dysfunction, and the transition from stable to unstable disease. The session discusses tools for evaluating disease burden including stress testing, coronary CT angiography, invasive angiography, FFR, iFR, and intracoronary imaging. Case-based discussions guide clinicians on interpreting mixed disease patterns, atypical symptoms, female-specific ischemia patterns, and presentations in diabetics and older adults.

A central theme focuses on integrating advanced coronary disease management strategies. Attendees will explore personalized approaches using antiplatelet therapy, statins, ACE inhibitors, beta-blockers, anti-anginals, diabetes therapies, and emerging agents such as PCSK9 inhibitors and inclisiran. Comprehensive lifestyle modification, cardiac rehabilitation, and risk factor control are emphasized as essential elements.

Advanced discussions include indications for revascularization, choosing between PCI and CABG, shared decision-making, and monitoring for restenosis or progression. By the end, participants will understand how to deliver holistic, evidence-based care across the entire coronary disease continuum.